These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21169250)

  • 21. Surgeons: A Future Role in Clinical Trials?
    Rusch VW
    Oncologist; 1997; 2(3):V-VI. PubMed ID: 10388050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted therapies for non-small cell lung cancer.
    Dempke WC; Suto T; Reck M
    Lung Cancer; 2010 Mar; 67(3):257-74. PubMed ID: 19914732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Explaining marginal benefits to patients, when "marginal" means additional but not necessarily small.
    Smith TJ; Hillner BE
    Clin Cancer Res; 2010 Dec; 16(24):5981-6. PubMed ID: 21169251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New drugs in prostate cancer.
    Armstrong AJ; Carducci MA
    Curr Opin Urol; 2006 May; 16(3):138-45. PubMed ID: 16679849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternatives to animal experimentation in basic research.
    Gruber FP; Hartung T
    ALTEX; 2004; 21 Suppl 1():3-31. PubMed ID: 15586255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emerging treatment with systemic chemotherapy and targeted agents for biliary cancers.
    Boku N
    Curr Opin Investig Drugs; 2010 Jun; 11(6):653-60. PubMed ID: 20496260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted therapy: for kids, too.
    Corey SJ
    Pediatr Blood Cancer; 2005 Oct; 45(5):623-34. PubMed ID: 15704219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer drugs. Weighing the risks and benefits.
    Bren L
    FDA Consum; 2007; 41(1):10-9. PubMed ID: 17342832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methodological and design issues in clinical trials of new neuroleptics: an overview.
    Awad AG
    Br J Psychiatry Suppl; 1993 Dec; (22):51-7. PubMed ID: 7906524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspective on the pipeline of drugs being developed with modulation of DNA damage as a target.
    Plummer R
    Clin Cancer Res; 2010 Sep; 16(18):4527-31. PubMed ID: 20823148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting the B cell in rheumatoid arthritis.
    Cohen SB
    Best Pract Res Clin Rheumatol; 2010 Aug; 24(4):553-63. PubMed ID: 20732652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New science-based endpoints to accelerate oncology drug development.
    Kelloff GJ; Sigman CC
    Eur J Cancer; 2005 Mar; 41(4):491-501. PubMed ID: 15737552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Unique adverse effects of molecular targeted drugs].
    Kobayashi T; Ichikawa W
    Nihon Rinsho; 2010 Oct; 68(10):1929-35. PubMed ID: 20954342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Emerging targeted therapies in cancer.
    Chirieac LR
    Arch Pathol Lab Med; 2012 May; 136(5):474-5. PubMed ID: 22540297
    [No Abstract]   [Full Text] [Related]  

  • 38. Basket Cases: How Real-World Testing for Drugs Approved Based on Basket Trials Might Lead to False Diagnoses, Patient Risks, and Squandered Resources.
    Ramsey SD; Shankaran V; Sullivan SD
    J Clin Oncol; 2019 Dec; 37(36):3472-3474. PubMed ID: 31233352
    [No Abstract]   [Full Text] [Related]  

  • 39. Keynote comment: Deprivation and survival in patients with cancer: we know so much, but do so little.
    Munro AJ
    Lancet Oncol; 2005 Dec; 6(12):912-3. PubMed ID: 16321752
    [No Abstract]   [Full Text] [Related]  

  • 40. Mitochondria as a pharmacological target: a clue for efficacy and a reason for toxicity.
    Apostolova N
    Curr Pharm Des; 2011; 17(20):1984-5. PubMed ID: 21718243
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.